Acute Hyperglycemia Without Ketosis Related Movement Disorders: A Case Series
Objective: report 2 patients with different types of movement disorders (MD) revealing an Acute hyperglycemia without ketosis (AHWK). Background: neurological complications of diabetes are multiple,…Lingual dystonia etiology spectrum in a tertiary center
Objective: To describe a group of patients with LP regarding clinical presentation, etiology, and treatment. Background: Lingual dystonia (LD) is a rare, disabling and difficult…A Case of Disabling Orofacial Dyskinesias Caused by Lupus Anticoagulant
Objective: We describe a 93-year-old man with subacute, progressive onset of disabling orofacial dyskinesias (OD), found to have positive lupus anticoagulant (LA) and anti-beta2-glycoprotein IgA…The clinical spectrum of movement disorders associated with neuronal antibodies
Objective: To describe the clinical and treatment characteristics of movement disorders associated with antibodies (Abs) against neuronal synaptic extracellular (NMDAR, LGI1, CASPR2, IgLON5, Glycine receptors…SLC20A2 mutation manifesting as very-late onset orofacial dyskinesia
Objective: We report two cases of genetically confirmed PFBC with a SLC20A2 mutation that presented with very-late onset orofacial dyskinesia. Background: Primary familial brain calcification…Oromandibular Dystonia as an Initial Manifestation of Parkinson’s Disease: 2 Case Reports
Objective: We describe an unusual initial manifestation of Parkinson’s disease, consisting of oromandibular dystonia. We also discuss the role of DaTscan SPECT imaging in the…Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation
Objective: To evaluate the efficacy of calcium disodium edetate (CaNa2EDTA) chelation as a treatment for acquired hepatocerebral degeneration. Background: Acquired hepatocerebral degeneration is a rare…Kratom withdrawal induced orobuccal dyskinesia
Objective: To describe the new observation of Kratom withdrawal that presented with the choreiform movement of lips and tongue. Background: Orobuccal dyskinesia is the hyperkinetic…Auto-antibodies and clinical-imaging associations in patients with Movements Disorders from a Neurological Institute in Mexico
Objective: Determine the prevalence of systemic and anti-neuronal antibodies in Movement Disorders patients from a third-level neurological hospital. Background: Autoimmunity is a common cause of…Unusual prolonged survival in multiple system atrophy: A case report
Objective: To present a case of a patient with multiple system atrophy (MSA) parkinsonian subtype (MSA-P) with unusual long disease duration. Background: MSA is a…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.